ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 337

$725K Total Retail Price of All Prescriptions

Rank: 27 out of 337

560 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 560 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 560 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 15,054 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
METOPROLOL TARTRATE 513 491 1 6
LEVOTHYROXINE SODIUM 511 486 2 5
LISINOPRIL 508 479 3 2
SIMVASTATIN 495 434 4 1
WARFARIN SODIUM 485 484 5 11
GABAPENTIN 462 450 6 20
AMLODIPINE BESYLATE 460 448 7 3
TRAZODONE HCL 452 441 8 16
OMEPRAZOLE 432 431 9 4
ATENOLOL 415 403 10 10
FUROSEMIDE 351 350 11 8
DONEPEZIL HCL 324 324 12 22
MIRTAZAPINE 317 312 13 27
HYDROCHLOROTHIAZIDE 311 301 14 9
PRAVASTATIN SODIUM 308 305 15 14
CITALOPRAM HBR 303 300 16 17
HYDROCODONE-ACETAMINOPHEN 222 195 S3 17 13
LOSARTAN POTASSIUM 217 203 18 15
SERTRALINE HCL 205 179 19 18
METFORMIN HCL 198 195 20 12
RANITIDINE HCL 167 145 21 30
ATORVASTATIN CALCIUM 167 165 21 7
ISOSORBIDE MONONITRATE ER 160 160 23 70
PREDNISONE 156 156 24 40
DIOVAN 155 155 25 26
METOPROLOL SUCCINATE 150 150 26 21
TAMIFLU 123 119 27 147
CYMBALTA 121 115 28 59
BUSPIRONE HCL 110 110 29 129
FLUTICASONE PROPIONATE 108 100 30 34
TAMSULOSIN HCL 106 106 31 25
LANTUS 105 95 32 49
ALLOPURINOL 105 104 32 28
NAMENDA 104 104 34 35
LOSARTAN-HYDROCHLOROTHIAZIDE 102 99 35 60
DIGOXIN 98 89 36 58
GLIPIZIDE 93 83 37 45
POTASSIUM CHLORIDE 88 85 38 62
LABETALOL HCL 87 78 39 149
LOVASTATIN 82 80 40 24
QUETIAPINE FUMARATE 80 80 41 61
NORTRIPTYLINE HCL 74 58 42 260
SINGULAIR 73 73 43 113
CLOPIDOGREL 72 72 44 42
OXYCODONE HCL 71 71 S2 45 63
DILTIAZEM 24HR CD 71 71 45 104
LIDODERM 69 56 47 82
SPIRIVA 67 67 48 43
PAROXETINE HCL 67 67 48 46
RISPERIDONE 66 66 50 72
ALENDRONATE SODIUM 66 62 50 19
METHYLPHENIDATE HCL 65 65 52 297
FLUOXETINE HCL 64 45 53 57
NYSTATIN 64 51 53 125
ESCITALOPRAM OXALATE 63 63 55 66
RAMIPRIL 63 63 55 80
ZOLPIDEM TARTRATE 62 62 57 23
DOXAZOSIN MESYLATE 60 60 58 68
FENOFIBRATE 58 58 59 48
PANTOPRAZOLE SODIUM 56 56 60 36
LEVETIRACETAM 55 47 61 112
FAMOTIDINE 54 50 62 115
KETOCONAZOLE 54 48 62 196
GLYBURIDE 53 53 R 64 53
FINASTERIDE 52 52 65 83
CARBIDOPA-LEVODOPA 52 52 65 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.